Show simple item record

Authordc.contributor.authorCabello Andrade, Juan Francisco
Authordc.contributor.authorNovoa, Fernando
Authordc.contributor.authorHuff, Hanalise V.
Authordc.contributor.authorColombo Campbell, Marta Paulina
Admission datedc.date.accessioned2021-12-10T15:32:24Z
Available datedc.date.available2021-12-10T15:32:24Z
Publication datedc.date.issued2021
Cita de ítemdc.identifier.citationInt. J. Neonatal Screen. 2021, 7, 6.es_ES
Identifierdc.identifier.other10.3390/ijns7010006
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/183150
Abstractdc.description.abstractNewborn screening (NBS) has widely been utilized in developed countries as a costeffective public health strategy that reduces morbidity and mortality. Developing countries, however, are new to the NBS scene and have their own unique challenges, both in instituting the program as well as effectively acting on the results. NBS offers numerous ethical issues on a global scale, however, here we argue that there are unique ethical issues surrounding the development and expansion of newborn screening in Latin America given its highly heterogenous population. Once a NBS program is effectively instated, ethical considerations continue when pursuing expansion of screening to include further conditions. While Latin America grapples with the ethics of expanded newborn screening (ENBS), some developed countries discuss utility of genomic sequencing technologies in the newborn population. When the ability to detect further pathology is expanded, one must know what to do with this information. As rare diseases are identified either on ENBS or via genome sequencing, access to treatments for these rare diseases can be a real challenge. If we consider newborn screening as a global initiative, then we need more than a deontology approach to analyze these challenges; we need an approach that considers the unique characteristics of each territory and tremendous heterogeneity that exists prior to the implementation of these programs. As genomic technology advances further in the developed world, while some developing countries still lack even basic newborn screening, there is a further widening of the gap in global health disparities. The question is posed as to who has responsibility for these newborns’ lives on an international level. Without an approach towards newborn screening that accounts for the diverse global population, we believe optimal outcomes for newborns and families across the world will not be achieved.es_ES
Lenguagedc.language.isoenes_ES
Publisherdc.publisherMDPIes_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
Sourcedc.sourceInternational Journal of Neonatal Screeninges_ES
Keywordsdc.subjectEthicses_ES
Keywordsdc.subjectChilees_ES
Keywordsdc.subjectLatin Americaes_ES
Keywordsdc.subjectNewborn genome sequencinges_ES
Keywordsdc.subjectNewborn sequencinges_ES
Keywordsdc.subjectNewborn sequencinges_ES
Títulodc.titleExpanded newborn screening and genomic sequencing in Latin America and the resulting social justice and ethical considerationses_ES
Document typedc.typeArtículo de revistaes_ES
dc.description.versiondc.description.versionVersión publicada - versión final del editores_ES
dcterms.accessRightsdcterms.accessRightsAcceso abiertoes_ES
Catalogueruchile.catalogadorcfres_ES
Indexationuchile.indexArtículo de publícación WoSes_ES
Indexationuchile.indexArtículo de publicación SCOPUSes_ES


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States